These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17179978)

  • 41. Tumour volume and high grade tumour volume are the best predictors of pathologic stage and biochemical recurrence after radical prostatectomy.
    Chun FK; Briganti A; Jeldres C; Gallina A; Erbersdobler A; Schlomm T; Walz J; Eichelberg C; Salomon G; Haese A; Currlin E; Ahyai SA; Bénard F; Huland H; Graefen M; Karakiewicz PI
    Eur J Cancer; 2007 Feb; 43(3):536-43. PubMed ID: 17222546
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Visual estimation of the tumor volume in prostate cancer: a useful means for predicting biochemical-free survival after radical prostatectomy?
    May M; Siegsmund M; Hammermann F; Loy V; Gunia S
    Prostate Cancer Prostatic Dis; 2007; 10(1):66-71. PubMed ID: 17189956
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prostate-specific antigen adjusted for total prostatic tumor volume as a predictor for outcome after radical prostatectomy.
    Hayashi N; Urashima M; Ikemoto I; Kuruma H; Arai Y; Kuwao S; Baba S; Egawa S
    Prostate Cancer Prostatic Dis; 2007; 10(1):60-5. PubMed ID: 17003775
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oncological and functional results of antegrade radical retropubic prostatectomy for the treatment of clinically localised prostate cancer.
    Carini M; Masieri L; Minervini A; Lapini A; Serni S
    Eur Urol; 2008 Mar; 53(3):554-61. PubMed ID: 17683854
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predictive significance of surgical margin status after prostatectomy for prostate cancer during PSA era.
    Mann MJ; DeCastro GJ; Desai M; Benson MC; McKiernan JM
    Urology; 2008 Dec; 72(6):1203-7. PubMed ID: 18674807
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlation between upgrading of prostate biopsy and biochemical failure and unfavorable pathology after radical prostatectomy.
    Ozden C; Oztekin CV; Ugurlu O; Gokkaya S; Yaris M; Memis A
    Urol Int; 2009; 83(2):146-50. PubMed ID: 19752607
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The maximum tumour length in biopsy cores as a predictor of outcome after radical prostatectomy.
    Hayashi N; Urashima M; Kuruma H; Arai Y; Kuwao S; Iwamura M; Egawa S
    BJU Int; 2008 Jan; 101(2):175-80. PubMed ID: 17850362
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Limited pelvic lymph node dissection does not improve biochemical relapse-free survival at 10 years after radical prostatectomy in patients with low-risk prostate cancer.
    Weight CJ; Reuther AM; Gunn PW; Zippe CR; Dhar NB; Klein EA
    Urology; 2008 Jan; 71(1):141-5. PubMed ID: 18242383
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Positive predictive value of high-grade prostatic intraepithelial neoplasia in initial core needle biopsies of prostate adenocarcinoma--a study with complete sampling of hemi-prostates with corresponding negative biopsy findings.
    Delatour NL; Mai KT
    Urology; 2008 Sep; 72(3):623-7. PubMed ID: 18279923
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antegrade radical retropubic prostatectomy with preliminary ligation of vascular pedicles in 614 consecutive patients.
    Kawakami S; Fukui I; Yonese J; Okubo Y; Yamamoto S; Tsukamoto T; Ishikawa Y
    Jpn J Clin Oncol; 2007 Jul; 37(7):528-33. PubMed ID: 17720739
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumour length of the largest focus predicts prostate-specific antigen-based recurrence after radical prostatectomy in clinically localized prostate cancer.
    Mizuno R; Nakashima J; Mukai M; Okita H; Kosugi M; Kikuchi E; Miyajima A; Nakagawa K; Ohigashi T; Oya M
    BJU Int; 2009 Nov; 104(9):1215-8. PubMed ID: 19389009
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The relationship between the extent of surgical margin positivity and prostate specific antigen recurrence in radical prostatectomy specimens.
    Marks RA; Koch MO; Lopez-Beltran A; Montironi R; Juliar BE; Cheng L
    Hum Pathol; 2007 Aug; 38(8):1207-11. PubMed ID: 17490720
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early prostate cancer antigen expression in predicting presence of prostate cancer in men with histologically negative biopsies.
    Hansel DE; DeMarzo AM; Platz EA; Jadallah S; Hicks J; Epstein JI; Partin AW; Netto GJ
    J Urol; 2007 May; 177(5):1736-40. PubMed ID: 17437801
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of obesity on the utility of preoperative prostate-specific antigen velocity to predict for relapse after prostatectomy: a report from the SEARCH database.
    King CR; Freedland SJ; Terris MK; Kane CJ; Amling CL; Aronson WJ; Presti JC
    Urology; 2007 May; 69(5):921-6. PubMed ID: 17482935
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy.
    Smith JA; Chan RC; Chang SS; Herrell SD; Clark PE; Baumgartner R; Cookson MS
    J Urol; 2007 Dec; 178(6):2385-9; discussion 2389-90. PubMed ID: 17936849
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of modern pathological criteria for positive margins in radical prostatectomy specimens and their use for predicting biochemical recurrence.
    Bong GW; Ritenour CW; Osunkoya AO; Smith MT; Keane TE
    BJU Int; 2009 Feb; 103(3):327-31. PubMed ID: 19007381
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of prostate-specific antigen testing on the clinical and pathological outcomes after radical prostatectomy for Gleason 8-10 cancers.
    Boorjian SA; Karnes RJ; Rangel LJ; Bergstralh EJ; Frank I; Blute ML
    BJU Int; 2008 Feb; 101(3):299-304. PubMed ID: 17922854
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stromogenic prostatic carcinoma pattern (carcinomas with reactive stromal grade 3) in needle biopsies predicts biochemical recurrence-free survival in patients after radical prostatectomy.
    Yanagisawa N; Li R; Rowley D; Liu H; Kadmon D; Miles BJ; Wheeler TM; Ayala GE
    Hum Pathol; 2007 Nov; 38(11):1611-20. PubMed ID: 17868773
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Twenty-four-month postradiation prostate biopsies are strongly predictive of 7-year disease-free survival: results from a Canadian randomized trial.
    Crook JM; Malone S; Perry G; Eapen L; Owen J; Robertson S; Ludgate C; Fung S; Lockwood G
    Cancer; 2009 Feb; 115(3):673-9. PubMed ID: 19117039
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Men with organ-confined prostate cancer and positive surgical margins develop biochemical failure at a similar rate to men with extracapsular extension.
    Psutka SP; Feldman AS; Rodin D; Olumi AF; Wu CL; McDougal WS
    Urology; 2011 Jul; 78(1):121-5. PubMed ID: 21411125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.